Ronald W. Pero
Director Técnico/Científico/I+D en RezGen5 Ltd. .
Perfil
Ronald W.
Pero is a Professor-Emeritus at the University of Lund.
He is also the Chief Scientific Officer at RezGen5 Ltd.
and a Founding Member of Campamed, Inc. and Deep South Partners LLC.
Previously, he was a Founding Member of Oncotelic Therapeutics, Inc. and Optigenex, Inc.
Cargos activos de Ronald W. Pero
| Empresas | Cargo | Inicio |
|---|---|---|
RezGen5 Ltd.
 RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Director Técnico/Científico/I+D | - |
| University of Lund | Corporate Officer/Principal | - |
| Campamed, Inc. | Corporate Officer/Principal | - |
| Deep South Partners LLC | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Ronald W. Pero.
| Empresas | Cargo | Fin |
|---|---|---|
| OPTIGENEX INC. | Corporate Officer/Principal | - |
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| OPTIGENEX INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
RezGen5 Ltd.
RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Health Technology |
| Campamed, Inc. | |
| Deep South Partners LLC |
- Bolsa de valores
- Insiders
- Ronald W. Pero